Health Condition 1: null- Pediatric Oncology Patients Referred To The Department Of Palliative Medicine.
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
Dr Mary Muckaden
Eligibility
Inclusion criteria
Inclusion criteria: 1. Pediatric oncology patients referred to the department of Palliative Medicine with advance cancer having pediatric locally advanced or metastatic solid organ cancer, or a relapsed or refractory hematolyphoid cancer patients. 2. Parents willing to participate in the study and signing the informed consent. 3. Ascent from the children aged 7 years and above 4. Able to understand and complete the questionnaire.
Exclusion criteria
Exclusion criteria: 1. Not able to understand Hindi or Marathi. 2. Participants not willing to consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Outcomes of the study is to describe the validity, reliability and feasibility of using the translated Hindi and Marathi versions of PediQUEST- MSAS for children with advanced cancer. The English version was deliberately not included for validation in our study as we get very few English-speaking patients in pediatric palliative care out patients.Timepoint: 1. After consenting. 2. Before starting treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To establish the content validity, inter subscale correlation of the Hindi and Mararthi translated versions of PediQUEST Memorial Symptom assessment scale 2. To prove the reliability of translated versions PediQUEST Memorial Symptom assessment scale measured by evaluating internal consistency using CRONBACHâ??S of alpha.Timepoint: 1. After consenting. 2. Before starting treatment. | — |
Countries
India
Contacts
Public ContactDr Krithika Shinde
Tata Memorial Hospital
Outcome results
None listed